From Lignin to Value-Added Pharmaceutical Intermediates Based on a Benzylic Oxidation Method with O₂

Area of Science:

• Green Chemistry
• Catalysis
• Biomass Valorization

Background:

• Lignin, a complex biopolymer, is an abundant but underutilized component of biomass.
• Efficient conversion of lignin into high-value chemicals remains a significant challenge in sustainable chemistry.
• Pharmaceutical intermediates are crucial building blocks for drug synthesis, often derived from petrochemical sources.

Purpose of the Study:

• To develop a catalytic strategy for converting lignin into pharmaceutical intermediates.
• To establish a highly selective lignin depolymerization method.
• To implement a green benzylic oxidation process using molecular oxygen.

Main Methods:

• Selective catalytic depolymerization of lignin to yield 4-ethylphenol.
• Green benzylic oxidation of 4-ethylphenol using O2 as the oxidant.
• A streamlined 5-step process for generating pharmaceutical intermediates from 4-ethylphenol.

Main Results:

• Successfully converted lignin into 4-ethylphenol with high selectivity.
• Efficiently generated various pharmaceutical intermediates through a subsequent 5-step catalytic process.
• Demonstrated substantial economic benefits due to the efficient utilization of lignin.

Conclusions:

• The presented catalytic strategy offers an innovative solution for lignin valorization.
• This method provides a green and economically viable pathway for producing pharmaceutical intermediates.
• The study highlights the potential of biomass-derived platform chemicals in sustainable chemical synthesis.